Contribution of plasmid DNA to hepatotoxicity after systemic administration of lipoplexes

Human Gene Therapy

Volumn 12, Issue 6, 2001, Pages 685-696

  Loisel, S ^a   Le Gall, C ^a   Doucet, L ^b   Ferec, C ^a   Floch, V ^a  

^a BREST UNIVERSITY HOSPITAL   (France)

^b CHU MORVAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; LUCIFERASE; PHOSPHOLIPID DERIVATIVE; PLASMID DNA;

ANIMAL TISSUE; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; CPG ISLAND; CYTOKINE PRODUCTION; DNA VECTOR; GENE EXPRESSION; LIVER INJURY; LIVER TOXICITY; LUNG; MOUSE; NONHUMAN; TRANSGENE;

ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; CATIONS; CELLS, CULTURED; CPG ISLANDS; DNA METHYLATION; DRUG CARRIERS; FATTY ACIDS, MONOUNSATURATED; FEMALE; FLUORESCENT DYES; GENE TRANSFER TECHNIQUES; INJECTIONS, INTRAVENOUS; LIPIDS; LIPOSOMES; LIVER; LUCIFERASES; LUNG; MICE; MICE, INBRED STRAINS; PLASMIDS; QUATERNARY AMMONIUM COMPOUNDS; TRANSFECTION;

ANIMALIA;

EID: 0035831629     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303401300057405     Document Type: Article

References (23)

1. Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: A double-blind placebo-controlled trial
2. Modulation of the inflammatory properties and hepatotoxicity of recombinant adenovirus vectors by the viral E4 gene products
3. Lipofection: A highly efficient lipid-mediated DNA transfection procedure
4. Systemic administration of cationic phosphonolipids/DNA complexes and the relationship between formulation and lung transfection efficiency
5. Cationic substitution in cationic phosphonolipids: A new concept to improve transfection activity and decrease cellular toxicity
6. Cationic lipids enhance cytokine and cell influx levels in the lung following administration of plasmid:cationic lipid complexes
7. Polyethylenimine-based intravenous delivery of transgenes to mouse lung
8. Comparison between intratracheal and intravenous administration of liposome-DNA complexes for cystic fibrosis lung gene therapy
9. Cationic phosphonolipids containing quaternary phosphonium and arsonium groups for DNA transfection with good efficiency and low cellular toxicity
10. Direct immunologic activities of CpG DNA and implications for gene therapy
11. CpG motifs in bacterial DNA trigger direct B-cell activation
12. Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs
13. Cationic phosphonolipids as non viral vectors for D.N.A. transfection
14. In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes
15. Effect of immune response on gene transfer to the lung via systemic administration of cationic lipidic vectors
16. Bacterial DNA is implicated in the inflammatory response to delivery of DNA/DOTAP to mouse lungs
17. Cytokines and the hepatic acute-phase response
18. CpG motifs in bacterial DNA cause inflammation in the lower respiratory tract
19. Characterization of cationic liposome-mediated gene transfer in vivo by intravenous administration
20. The inhibitory role of CpG immunostimulatory motifs in cationic lipid vector-mediated transgene expression in vivo
21. Systemic gene therapy: Biodistribution and long-term expression of a transgene in mice
22. Contribution of plasmid DNA to inflammation in the lung after administration of cationic lipid:pDNA complexes
23. Systemic gene expression after intravenous DNA delivery into adult mice